PALO ALTO, Calif., May 31, 2025--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and its research collaborators today presented results of the largest study ...
Colonoscopy screening exams that are recommended for older U.S. adults failed to reduce the risk of death from colon cancer in a 10-year study that questions the benefits of the common procedure.
According to Medscape, the National Comprehensive Cancer Network's colon cancer guidelines have changed to reflect that patients with low-risk stage III colon cancers can be treated with a shorter ...
Colonoscopy screening exams that are recommended for older U.S. adults failed to reduce the risk of death from colon cancer in a 10-year study that questions the benefits of the common procedure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback